AzTrials
AzTrials

Tracheal IntubationNCT00847184

Comparison of Airtraq Versus MacIntosh Intubation Via Nasal Approach

A study testing Intubation and Airtraq in people with Tracheal Intubation, run by Kliniken Essen-Mitte at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Time, success rate, and number of optimising maneuvers for tracheal intubation via the nasal approach are not different when Aitraq technique is used compared to a standard MacIntosh blade. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Tracheal Intubation
What is being tested?
Intubation and Airtraq
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteGermany
Study dates
Feb 2009to Nov 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Scheduled for nasal intubation
  • Adult

Who cannot join

  • Age under 18 years

Trial locations and contacts

1 site in 1 country.

Germany1 site, 1 recruiting
  • Prof. Dr. Harald Groeben

    Essen, 45136

    Harald Groeben, M.D., ##49 201 174 31109, h.groeben@kliniken-essen-mitte.de

    Harald Groeben, M.D.

    Recruiting

Other trials in Germany

About this study

Official title: Comparison of Airtraq vs. MacIntosh Intubation Via Nasal Approach

Time, success rate, and number of optimising maneuvers for tracheal intubation via the nasal approach are not different when Aitraq technique is used compared to a standard MacIntosh blade.

Read the detailed description

One hundred adult patients with an expected easy intubation and 100 patients with an expected difficult intubation are enrolled. Intubations are performed by two experienced fully boarded anesthesiologists. The design of the study is prospective and randomised.

Being tested
Intubation, Airtraq
Keywords
nasal intubation, Aitraq, difficult intubation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IntubationDevice

    Intubation using the standard MacIntosh blade

  • AirtraqDevice

    Also called Aitraq, Prodol Meditec S.A., Vizcaya, Spain

    Intubation with the use of the Airtraq technique

Study groups in NCT00847184
Study groupRoleWhat they receive
1. AirtraqActive comparatorIntubation with the use of the Airtraq technique
Receives: Device: Airtraq
2. MacIntoshActive comparatorIntubation using the standard MacIntosh blade
Receives: Device: Intubation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time for intubation

    Measured: 10 month

Secondary outcomes (1)
  1. Success rate for intubation

    Measured: 10 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2009 (estimated)
  2. Study startFeb 2009
  3. Primary completionNov 2009 (estimated)
  4. Study completionNov 2009 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00847184
Sponsor's protocol ID
Airtraqnasal2009
Status last verified
Feb 2009
First submitted
11 Feb 2009
Last updated
19 Feb 2009
Results posted
No
Data monitoring committee
No

Publications

  • Maharaj CH, Higgins BD, Harte BH, Laffey JG. Evaluation of intubation using the Airtraq or Macintosh laryngoscope by anaesthetists in easy and simulated difficult laryngoscopy--a manikin study. Anaesthesia. 2006 May;61(5):469-77. doi: 10.1111/j.1365-2044.2006.04547.x.

    PubMed 16674623

Questions about this trial

What is this clinical trial studying?

A study testing Intubation and Airtraq in people with Tracheal Intubation, run by Kliniken Essen-Mitte at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Feb 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time for intubation (time frame: 10 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00847184, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in